Our researchers are fighting the coronavirus pandemic with innovative approaches. With your donation you can support them in developing drugs and vaccines against the virus or in deciphering the mechanisms of disease development and progression. Here you can find out all about donation opportunities.
Learn more about how the HZI, with its translational focus, will help to facilitate a faster and more targeted approach when it comes to fighting and preventing existing, emerging or recurring infectious diseases.
Here you can find out more about the scientific results of the HZI in the research topics ”Bacterial and Viral Pathogens”, “Immune Response and Interventions” and “Anti-Infectives”.
Around 900 employees in research, administration and infrastructure, and about 220 visiting scientists from 40 different countries are employed at the Helmholtz Centre for Infection Research. To ensure top quality research we need top quality employees. Your creativity and innovative capabilities are the basis for the long-term success of our work. That's why we undertake a great deal to attract the best people to us. Learn more about this.
From 1 July 2023, Prof Josef Penninger takes over the Scientific Management of the Helmholtz Centre for Infection Research (HZI). Here you can find content and background information for media coverage. [read more]
The coronaviruses are a family of viruses that includes a series of very different pathogens. These viruses usually infect mammals, rodents, and birds, but only few coronaviruses adapted to humans. They did this with great success: About one third of all typical "common colds" and some cases of diarrhoea as well are caused by these RNA Viruses, which are the largest of their kind. We have compiled more information about the coronaviruses for you.
With the pathogen SARS-CoV-2, a novel virus that can cause respiratory diseases and pneumonia has been spreading worldwide since the end of 2019. Here we will keep you informed about current developments in research and provide answers to the most important questions.
HomePressVideos & PodcastsVideos
Results 1 to 9 of total 63
2023-11-28
The funding guideline for the establishment of German-Ukrainian cores of excellence in Ukraine was already initiated by the Federal Ministry of Education and Research before the start of the Russian war of aggression against Ukraine. In addition to the original intention of intensifying scientific collaboration between the two countries, the four cores of excellence funded now also…
2023-11-17
Bioinformatician Prof Alice McHardy uses computational techniques to research the human microbiome as well as viral and bacterial pathogens. She heads the department “Computational Biology for Infection Research” at BRICS (Braunschweig Integrated Center of Systems Biology), a joint institution of the HZI and Technische Universität Braunschweig. The department “Computational…
The digitalization of the life sciences opens up completely new potential for tackling common diseases such as cancer, cardiovascular diseases, diabetes and neurodegenerative diseases such as Alzheimer's. The Center therefore focuses on linking research data, clinical data and patient care data, the use of artificial intelligence and causal methods in medicine. Causal methods make…
2023-11-16
The basis for the developed strategy to produce new active ingredients is the compound lignin. Lignin is a biopolymer found in plants and is responsible for their lignification and stability. Chemically, lignin is made up of a large number of various aromatic compounds that are linked together. If lignin is broken down into its individual building blocks, these can then be used to…
2023-11-09
At the DZIF General Assembly on 8 November 2023, Prof Thomas Pietschmann was unanimously elected as a new member of the five-person DZIF Executive Board. In addition to his roles at three closely linked DZIF member institutions — the HZI in Braunschweig and the MHH and TWINCORE in Hannover — Pietschmann has held a variety of other roles at the DZIF over many years. Among other…